Toxicity reduction required for MRI-guided radiotherapy to be cost-effective in the treatment of localized prostate cancer

This is the first detailed economic assessment of MR-IGRT, and it suggests that MR-IGRT can be cost-effective for prostate cancer treatment through toxicity reduction alone.